Dynein axonemal heavy chain 9 (DNAH9)

**Dynein axonemal heavy chain 9 (DNAH9)** is a motor protein that forms a key component of the outer dynein arms (ODA) in the axoneme of motile cilia and flagella[1][3][4]. DNAH9 generates mechanical force through ATP hydrolysis, driving the beating motion essential for mucociliary clearance in the respiratory tract, left-right body asymmetry during embryonic development, and sperm motility[1][3][5][7]. DNAH9 primarily localizes to the distal portion of the ciliary axoneme, distinguishing ODA type 2 structure[5][7]. Loss-of-function mutations in DNAH9 cause a variant form of primary ciliary dyskinesia (PCD), characterized by chronic respiratory disease (due to defective mucociliary clearance), laterality defects (such as situs inversus), and in some cases, male infertility[3][5][7]. In affected tissues, ODAs containing DNAH9 are absent from the distal cilium, causing impaired ciliary motility that is generally more subtle than mutations in pan-axonemal ODA genes[3][5][7]. DNAH9 interacts with other axonemal proteins, including DNAH5, DNAI1, DNAI2, and the docking complex protein CCDC114, and is essential for the proper assembly of distal ODA type 2[5][7]. DNAH9 is not currently a therapeutic target for drugs and there are no approved drugs or biomarker strategies established for it. Experimental work, including mouse and organoid models, supports its critical role in respiratory and reproductive system function[7].

Other names

Dynein axonemal heavy chain 9DNAH17LDNEL1KIAA0357Dnahc9HL20HL-20DNAL1DYH9Axonemal beta dynein heavy chain 9Ciliary dynein heavy chain 9CILD40dynein, axonemal, heavy polypeptide 9